• Tacrine Hydrochloride Hydrate: Evidence for Cholinesterase I

  2026-05-12

  Tacrine hydrochloride hydrate (Tetrahydroaminacrine) is a benchmark acetylcholinesterase inhibitor used in Alzheimer's disease research. It enhances acetylcholine neurotransmission, inhibits amyloid-beta aggregation, and serves as a reference compound for developing multi-target neurodegenerative therapeutics.

• Sabutoclax: Strategic Pan-Bcl-2 Inhibition for Translational

  2026-05-12

  Explore how Sabutoclax, a potent pan-Bcl-2 inhibitor, bridges mechanism-driven cancer research and translational strategy. This article delivers actionable guidance for in vitro and in vivo assay design, critically evaluates evidence, and frames Sabutoclax as a next-generation tool for apoptosis-based oncology pipelines—moving beyond standard product summaries to offer strategic insights for translational researchers.

• Breast Cancer's Reliance on MCL-1: Insights from Canonical A

  2026-05-11

  This article examines Campbell et al.'s 2021 study clarifying that breast cancer's dependence on MCL-1 is driven by its canonical anti-apoptotic function. The findings highlight actionable targets for apoptosis induction in cancer cells and validate the use of selective MCL-1 inhibitors in translational research.

• Reelin Signaling: A Prerequisite for Ketamine’s Antidepressa

  2026-05-11

  This study elucidates that intact synaptic Reelin signaling is essential for ketamine's rapid antidepressant and synaptic potentiation effects in mouse models. Disruption of Reelin, Apoer2, or Src family kinases abolishes ketamine-mediated behavioral and synaptic responses, highlighting a molecular basis for nonresponsiveness in treatment-resistant depression.

• Cy3 Rabbit Anti-Goat IgG (H+L) Antibody: Workflow and QC Gui

  2026-05-10

  The Cy3 Rabbit Anti-Goat IgG (H+L) Antibody enables specific, sensitive detection of goat primary antibodies in fluorescence-based assays, including immunocytochemistry, IHC, flow cytometry, and ELISA. It should not be used for detection of non-goat primary antibodies or outside validated secondary antibody workflows. Proper storage and workflow integration are essential to maintain performance.

• FXR-KLF11 Axis: CDCA Protects Kidneys via JAK2/STAT3 Suppres

  2026-05-09

  This study reveals that Chenodeoxycholic Acid (CDCA), as a natural FXR agonist, protects against contrast-induced acute kidney injury (CI-AKI) by transcriptionally upregulating KLF11 and suppressing the JAK2/STAT3 pathway. The findings elucidate a distinct FXR-KLF11 signaling axis in renal protection, offering a mechanistic foundation for future prophylactic strategies targeting CI-AKI.

• FGF Signaling Drives Non-Cell Autonomous Resistance to Apopt

  2026-05-09

  This study uncovers how apoptotic stress triggers FGF2 release, activating MEK-ERK signaling and transiently upregulating anti-apoptotic BCL-2 proteins in neighboring cells. These findings reveal a non-cell autonomous pathway contributing to resistance against apoptosis-inducing cancer therapies and have implications for tissue repair and therapeutic design.

• Anlotinib Inhibits Angiogenesis by Targeting VEGFR2, PDGFRβ,

  2026-05-08

  The reference study demonstrates that Anlotinib hydrochloride acts as a potent multi-target tyrosine kinase inhibitor, directly suppressing VEGFR2, PDGFRβ, and FGFR1 to block tumor angiogenesis. These findings highlight its superior efficacy over established anti-angiogenic agents and provide a mechanistic basis for its application in cancer research.

• Astrocytic GAT-3 Controls Synaptic Transmission and Memory i

  2026-05-07

  This study uncovers the regulatory role of astrocytic GAT-3 in modulating synaptic transmission and memory formation within the dentate gyrus. Through precise in vitro and in vivo methodologies, it demonstrates that astrocyte-mediated GABA uptake critically shapes neural circuit dynamics, providing new mechanistic insight into cognitive processing and highlighting potential translational targets.

• NAT10-Mediated ac4C Modification Stabilizes OGA mRNA in Oocy

  2026-05-07

  Lin et al. (2022) demonstrate that NAT10 catalyzes ac4C modification to maintain OGA mRNA stability, which is essential for successful in vitro oocyte maturation. The study reveals a novel regulatory axis in epitranscriptomics, informing strategies to optimize assisted reproductive technologies.

• Lyso-Tracker Red DND-99: Precision Lysosome Labeling in Live

  2026-05-06

  Lyso-Tracker Red DND-99 empowers researchers to visualize lysosomal dynamics with high specificity and robust fluorescence in live-cell applications. This guide delivers an actionable workflow, troubleshooting tips, and experimental context for maximizing the probe’s performance—highlighting its unique role in studies ranging from immuno-oncology to advanced organelle tracking.

• Tofacitinib Repairs Inflammation and Mitochondrial Dysfuncti

  2026-05-06

  This study demonstrates that tofacitinib (CP-690550) reverses inflammation and mitochondrial dysregulation in GM-CSF-reprogrammed macrophages from rheumatoid arthritis (RA) models. Unlike anti-TNF, anti-IL6R, or metabolic inhibitors, tofacitinib achieves broad immunometabolic repair by suppressing STAT5 signaling and restoring regulatory macrophage phenotypes, informing translational strategies for immune modulation research.

• HyperPFU™ high-fidelity DNA polymerase: Practical PCR Guidan

  2026-05-05

  HyperPFU™ high-fidelity DNA polymerase is engineered to address the technical challenges of amplifying long, GC-rich, or otherwise difficult DNA templates, where standard Taq or lower-fidelity enzymes often fail. It is best suited for applications demanding high sequence accuracy and blunt-ended PCR products, but should not be used for protocols requiring 3'-A overhangs or sticky ends.

• Imeglimin Improves Mitochondrial Function in Carpal Tunnel S

  2026-05-05

  This study presents the first quantitative evidence that Imeglimin enhances mitochondrial function in subsynovial connective tissue (SSCT) cells from patients with idiopathic carpal tunnel syndrome (CTS). By integrating advanced mitochondrial assays—including permeability transition pore detection—the research reveals significant improvements in mitochondrial biogenesis, antioxidant activity, and reduced cell death, suggesting new therapeutic avenues for CTS.

• Berberine Modulates SIRT6-AMPK to Inhibit NLRP3 in AF Models

  2026-05-04

  This study reveals that berberine suppresses NLRP3 inflammasome activation and atrial fibrosis by upregulating the SIRT6-AMPK pathway in angiotensin II-induced murine models of atrial fibrillation (AF). The findings clarify the mechanistic link between metabolic signaling and inflammation in AF, offering translational pathways for research on cardiac fibrosis and arrhythmia.

16180 records 1/1079 page Next 12345 下5页 Last page